#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Hypoparathyroidism Monogenic diabetes Endometrial cancer Niemann-Pick disease X-linked lymphoproliferative syndrome Ovarian cancer Diffuse large B-cell lymphoma recurrent Fibrosarcoma Encephalitis autoimmune Transplant rejection Paget's disease of the vulva Central nervous system neoplasm Medullary thyroid cancer Hepatic cirrhosis Adenovirus infection More trials…
Learn about Rare Diseases

Rett syndrome – Basic Information Primary immunodeficiency syndrome Progressive multifocal leukoencephalopathy – Life with Disease Ornithine transcarbamoylase deficiency – Life with Disease Fragile X syndrome – Basic Information Optic glioma – Treatment Uterine leiomyosarcoma – Life with Disease Methylmalonic acidaemia Arterial tortuosity syndrome Primary immunodeficiency syndrome – Life with Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Lithium Carbonate Ciclesonide Tradipitant Nido-361 Triamcinolone Tenofovir Alafenamide Milrinone Sacituzumab Tirumotecan NALOXEGOL Metoclopramide Hydrochloride Ieramilimab Magnesium Oxide, Light Ly3556050 MALIC ACID Copper (64Cu) Chloride Etranacogene Dezaparvovec KETOROLAC TROMETAMOL SGT-003 Cinchocaine Hydrochloride Albaconazole More therapies…

Learn about Your Condition

Aortic disorder Pneumonia chlamydial Venous thrombosis limb Rhinitis allergic Hypopituitarism Oral neoplasm Left ventricular failure Intermittent claudication Chorea Embolism Foot deformity Ocular myasthenia Osteomyelitis Infectious pleural effusion HER2 negative breast cancer More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Hodgkin’s disease refractory

Study of Nivolumab and Chemotherapy Combination for Patients with Refractory Hodgkin’s Lymphoma

Recruiting

2 1 1 1
Investigated Diseases:
- Hodgkin’s disease refractory
Investigated Drugs:
- Nivolumab
Study of Ruxolitinib with Brentuximab or Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Hodgkin’s disease recurrent
- Hodgkin’s disease refractory
Investigated Drugs:
Study of Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma or Primary Mediastinal Large B-cell Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Primary mediastinal large B-cell lymphoma refractory
- Hodgkin’s disease refractory
Investigated Drugs:
- Pembrolizumab

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Hodgkin’s disease refractory

Study of Nivolumab and Chemotherapy Combination for Patients with Refractory Hodgkin’s Lymphoma

Study of Ruxolitinib with Brentuximab or Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Study of Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma or Primary Mediastinal Large B-cell Lymphoma

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies